SUDARSHAN PHARMA INDUSTRIES LIMITED

Scale -

Revenue is 703 Rs Cr; Annual Growth is 39 %; Continuous Growth over 3 years; in Top Quartile; 5 Year CAGR is 15 %
Ebitda is 60.03 Rs Cr; Annual Growth is 41 %; Continuous Growth over 3 years; in Top Quartile; 5 Year CAGR is 56 %
PBT is 7.51 Rs Cr; Annual Growth is 41 %; in Top Quartile; 5 Year CAGR is 48 %
PAT is 23.37 Rs Cr; Annual Growth is 47 %; Continuous Growth over 3 years; in Top Quartile; 5 Year CAGR is 49 %
Quarterly Revenue is 174 Rs Cr; in Top Quartile

Profitability -

PBDIT Margin is 8.53 %; Continuous Growth over 3 years; 5 Year CAGR is 36 %
PAT Margin is 3.32 %; Continuous Growth over 3 years; 5 Year CAGR is 30 %

Return -

ROE is 15.02 %; Annual Growth is 24 %; Continuous Growth over 3 years; 5 Year CAGR is 29 %
ROCE is 30.29 %; Continuous Growth over 3 years; in Top Quartile; 5 Year CAGR is 32 %
Asset Turnover is 135 %; in Top Quartile; Continuous Decline over 3 years; 5 Year CAGR is -18 %

ROA is 3.63 %; Continuous Decline over 3 years

Efficiency -

Inventory Turnover Ratio is 3.91; 5 Year CAGR is 631 %

Operating cash flow is -2.3 Rs Cr; Annual Decline is -107 %; in Bottom Quartile
Current Ratio is 1.07; Continuous Decline over 3 years; in Bottom Quartile
Quick Ratio is 0.6; Continuous Decline over 3 years; in Bottom Quartile

Solvancy -

Contingent Liabilities is 0 Rs Cr; Annual Decline is -100 %; in Top Quartile

Debt/Equity is 1.83; Annual Growth is 41 %; Continuous Growth over 3 years; in Top Quartile; 5 Year CAGR is 75 %
Long term Debt is 28.37 Rs Cr; Annual Growth is 171 %; in Top Quartile; 5 Year CAGR is 30 %
Total Debt is 283 Rs Cr; Annual Growth is 66 %; Continuous Growth over 3 years; in Top Quartile; 5 Year CAGR is 103 %

Quality -

Current Tax/PAT is 31 %; Continuous Decline over 3 years
Change in Inventories/Total Expenses is -11 %; in Bottom Quartile
Other Expenses/Total Expenses is 4 %; in Bottom Quartile; Annual Growth is 74 %; Continuous Growth over 3 years; 5 Year CAGR is 53 %

Operating cashflow/ebitda is -4 %; Annual Decline is -105 %
Operating cashflow/PAT is -10 %; Annual Decline is -104 %
Exceptional Items/PBT is 0 %; Annual Growth is 100 %; in Top Quartile

Quarterly Results- overall

Annual Results- Scale

Annual Results- Liquidity

Annual Results- Profitability/Return

Annual Results- Valuation

External Ecosystem

Sector

Major Subsidiaries/Associates

Key Clients

Products

Products

Product details

Operations

Capacity/ Production

Key Facilities

Key Certifications

Raw materials

Search: